Literature DB >> 17513640

Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies.

James S Anderson1, Noel R Rose, Jackie L Martin, Edmond I Eger, Dolores B Njoku.   

Abstract

BACKGROUND: Three cases of drug-induced liver injury (DILI) have been reported after desflurane anesthesia. However, no previous reports have detected serum autoantibodies such as that reported with DILI from halothane or isoflurane. METHODS AND
RESULTS: We describe the first documentation of cytochrome P450 2E1 IgG4 autoantibodies, as well as 58 kDa endoplasmic reticulum protein and trifluoroacetyl chloride hapten-specific IgG4 antibodies, in a patient who developed DILI after desflurane anesthesia.
CONCLUSIONS: These findings suggest that allergic and autoimmune mechanisms have critical roles in the development of desflurane DILI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513640      PMCID: PMC3650136          DOI: 10.1213/01.ane.0000263275.10081.47

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  16 in total

1.  Subcellular localization of trifluoroacetylated liver proteins in association with hepatitis following isoflurane.

Authors:  Dolores B Njoku; Sanjeeb Shrestha; Roger Soloway; Paul R Duray; Maria Tsokos; Mones S Abu-Asab; Lance R Pohl; A Brian West
Journal:  Anesthesiology       Date:  2002-03       Impact factor: 7.892

2.  Determination of IgG subclasses and avidity of antithyroid peroxidase antibodies in patients with subclinical hypothyroidism - a comparison with patients with overt hypothyroidism.

Authors:  L M Silva; J Chavez; M H B Canalli; C R Zanetti
Journal:  Horm Res       Date:  2003

3.  Ovalbumin-specific immunoglobulin G and subclass responses through the first 5 years of life in relation to duration of egg sensitization and the development of asthma.

Authors:  G H S Vance; C A Thornton; T N Bryant; J A Warner; J O Warner
Journal:  Clin Exp Allergy       Date:  2004-10       Impact factor: 5.018

4.  A novel model of drug hapten-induced hepatitis with increased mast cells in the BALB/c mouse.

Authors:  Dolores B Njoku; Monica V Talor; Delisa Fairweather; Sylvia Frisancho-Kiss; Oludare A Odumade; Noel R Rose
Journal:  Exp Mol Pathol       Date:  2005-01-06       Impact factor: 3.362

5.  Autoantibodies associated with volatile anesthetic hepatitis found in the sera of a large cohort of pediatric anesthesiologists.

Authors:  Dolores B Njoku; Robert S Greenberg; Mohammed Bourdi; Craig B Borkowf; Elizabeth M Dake; Jackie L Martin; Lance R Pohl
Journal:  Anesth Analg       Date:  2002-02       Impact factor: 5.108

6.  Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis.

Authors:  M Bourdi; W Chen; R M Peter; J L Martin; J T Buters; S D Nelson; L R Pohl
Journal:  Chem Res Toxicol       Date:  1996 Oct-Nov       Impact factor: 3.739

7.  Hepatotoxicity after desflurane anesthesia.

Authors:  J L Martin; D J Plevak; K D Flannery; M Charlton; J J Poterucha; C E Humphreys; G Derfus; L R Pohl
Journal:  Anesthesiology       Date:  1995-11       Impact factor: 7.892

8.  Hepatic necrosis associated with herpesvirus after anesthesia with desflurane and nitrous oxide.

Authors:  J Katz; J Magee; B Baker; E I Eger
Journal:  Anesth Analg       Date:  1994-06       Impact factor: 5.108

9.  Oxidative metabolism of halothane in the production of altered hepatocyte membrane antigens in acute halothane-induced hepatic necrosis.

Authors:  J Neuberger; G Mieli-Vergani; J M Tredger; M Davis; R Williams
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

10.  Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.

Authors:  E Eliasson; J G Kenna
Journal:  Mol Pharmacol       Date:  1996-09       Impact factor: 4.436

View more
  13 in total

Review 1.  [New technical developments for inhaled sedation].

Authors:  A Meiser; H Bomberg; T Volk; H V Groesdonk
Journal:  Anaesthesist       Date:  2017-04       Impact factor: 1.041

2.  CYP2E1 immunoglobulin G4 subclass antibodies after desflurane anesthesia.

Authors:  Chrysanthi Batistaki; George Michalopoulos; Paraskevi Matsota; Tzortzis Nomikos; Konstantinos Kalimeris; Maria Riga; Maria Nakou; Georgia Kostopanagiotou
Journal:  World J Hepatol       Date:  2014-05-27

Review 3.  Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury: a review.

Authors:  Dolores B Njoku
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-05       Impact factor: 4.481

4.  Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury.

Authors:  Dolores B Njoku; Zhaoxia Li; Nicole D Washington; Jenelle L Mellerson; Monica V Talor; Rajni Sharma; Noel R Rose
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

5.  IP-10 protects while MIP-2 promotes experimental anesthetic hapten - induced hepatitis.

Authors:  Dolores B Njoku; Zhaoxia Li; Jenelle L Mellerson; Rajni Sharma; Monica V Talor; Nicole Barat; Noel R Rose
Journal:  J Autoimmun       Date:  2009-01-07       Impact factor: 7.094

6.  Repeated exposure to modern volatile anaesthetics may cause chronic hepatitis as well as acute liver injury.

Authors:  Amanda Nicoll; David Moore; Dolores Njoku; Brad Hockey
Journal:  BMJ Case Rep       Date:  2012-11-06

7.  [Inhalational anesthetics].

Authors:  Jan Jedlicka; Philipp Groene; Julia Linhart; Elisabeth Raith; Da Vy Mu Stapha; Peter Conzen
Journal:  Anaesthesist       Date:  2021-04       Impact factor: 1.041

8.  Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis.

Authors:  Peiman Habibollahi; Nastaran Mahboobi; Sara Esmaeili; Saeid Safari; Ali Dabbagh; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2011-01       Impact factor: 0.660

Review 9.  The role of inhalational anesthetic drugs in patients with hepatic dysfunction: a review article.

Authors:  Hassan Soleimanpour; Saeid Safari; Farzad Rahmani; Hoorolnesa Ameli; Seyed Moayed Alavian
Journal:  Anesth Pain Med       Date:  2015-01-07

Review 10.  Drug-induced hepatotoxicity: metabolic, genetic and immunological basis.

Authors:  Dolores B Njoku
Journal:  Int J Mol Sci       Date:  2014-04-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.